Please wait
April 7, 2026
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read Item 4.01 of Form 8-K dated April 7, 2026, of Editas Medicine, Inc. and are in agreement with the statements contained in the last sentence of the first paragraph and the second and third paragraphs on page 1 therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ Ernst & Young LLP